Detection of Abnormalities in Type II Diabetic Patients Using Particle Filters

详细信息    查看全文

• 作者：Omid Vahidi ; R. Bhushan Gopaluni…
• 关键词：Organ dysfunction diagnosis ; In silico clinical trial ; Particle filters ; Type II diabetes compartmental modeling
• 刊名：Journal of Medical and Biological Engineering
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：35
• 期：2
• 页码：188-201
• 全文大小：517 KB
• 参考文献：1.DeFronzo, R. A. (2004). Pathogenesis of type 2 diabetes mellitus. Medical Clinics of North America, 88, 787-35. ix.CrossRef
  2.Ferrannini, E., Simonson, D. C., Katz, L. D., Reichard, G, Jr, Bevilacqua, S., Barrett, E. J., et al. (1988). The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism, 37, 79-5.CrossRef
  3.DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992). Pathogenesis of NIDDM. A balanced overview. Diabetes Care, 15, 318-68.CrossRef
  4.Groop, L. C., Widen, E., & Ferrannini, E. (1993). Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: Errors of metabolism or of methods? Diabetologia, 36, 1326-331.CrossRef
  5.Basu, A., Alzaid, A., Dinneen, S., Caumo, A., Cobelli, C., & Rizza, R. A. (1996). Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. Journal of Clinical Investigation, 97, 2351-361.CrossRef
  6.Campbell, P. J., Mandarino, L. J., & Gerich, J. E. (1988). Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism, 37, 15-1.CrossRef
  7.DeFronzo, R. A., Ferrannini, E., & Simonson, D. C. (1989). Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism, 38, 387-95.CrossRef
  8.Mitrakou, A., Kelley, D., Veneman, T., Jenssen, T., Pangburn, T., Reilly, J., & Gerich, J. (1990). Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes, 39, 1381-390.CrossRef
  9.Consoli, A., Nurjhan, N., Capani, F., & Gerich, J. (1989). Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes, 38, 550-57.CrossRef
  10.Alzaid, A. A., Dinneen, S. F., Turk, D. J., Caumo, A., Cobelli, C., & Rizza, R. A. (1994). Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. Journal of Clinical Investigation, 94, 2341-348.CrossRef
  11.Basu, R., Schwenk, W. F., & Rizza, R. A. (2004). Both fasting glucose production and disappearance are abnormal in people with mild and severe type 2 diabetes. American Journal of Physiology. Endocrinology and Metabolism, 287, E55–E62.CrossRef
  12.Basu, R., Chandramouli, V., Dicke, B., Landau, B., & Rizza, R. (2005). Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes, 54, 1942-948.CrossRef
  13.Basu, R., Basu, A., Johnson, C. M., Schwenk, W. F., & Rizza, R. A. (2004). Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. Diabetes, 53, 2042-050.CrossRef
  14.Basu, A., Dalla Man, C., Basu, R., Toffolo, G., Cobelli, C., & Rizza, R. A. (2009). Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism. Diabetes Care, 32, 866-72.CrossRef
  15.Iozzo, P., Hallsten, K., Oikonen, V., Virtanen, K. A., Kemppainen, J., Solin, O., et al. (2003). Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control. Journal of Clinical Endocrinology and Metabolism, 88, 2055-060.CrossRef
  16.Borra, R., Lautamaki, R., Parkkola, R., Komu, M., Sijens, P. E., Hallsten, K., et al. (2008). Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus. Metabolism, 57, 1445-451.CrossRef
  17.Pfeifer, M. A., Halter, J. B., & Porte, D, Jr. (1981). Insulin secretion in diabetes mellitus. American Journal of Medicine, 70, 579-88.CrossRef
  18.Polonsky, K. S., Given, B. D., Hirsch, L. J., Tillil, H., Shapiro, E. T., Beebe, C., et al. (1988). Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. New England Journal of Medicine, 318, 1231-239.CrossRef
  19.Luzi, L., & DeFronzo, R. A. (1989). Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. American Journal of Physiology, 257, E241–E246.
  20.Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999). The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Journal of Clinical Investigation, 104, 787-94.CrossRef
  21.Leahy, J. L. (2005). Pathogenesis of type 2 diabetes mellitus. Archives of Medical Research, 36, 197-09.CrossRef
  22.Guillausseau, P. J., Meas, T., Virally, M., Laloi-Michelin, M., Medeau, V., & Kevorkian, J. P. (2008). Abnormalities in insulin secretion in type 2 diabetes mellitu
• 作者单位：Omid Vahidi (1)
  R. Bhushan Gopaluni (2)
  Ezra Kwok (2)
  
  1. School of Chemical Engineering, Iran University of Science and Technology, Narmak, 16846-13114, Tehran, Iran
  2. Department of Chemical and Biological Engineering, University of British Columbia, 2360 East Mall, Vancouver, BC, V6T1Z3, Canada
  
• 刊物类别：Biomedical Engineering; Cell Biology; Imaging / Radiology;
• 刊物主题：Biomedical Engineering; Cell Biology; Imaging / Radiology;
• 出版者：Springer Berlin Heidelberg
• ISSN：2199-4757

文摘

This study proposes a strategy for detecting possible dysfunction of organs such as the liver, pancreas, muscles and adipose tissues in a group of type II diabetic patients. Several in silico clinical trials are performed on a previously developed type II diabetes model. Since the pancreatic insulin secretion rate and glucose metabolic rates of different organs represent the functional behavior of the corresponding organs, calculated values of these rates are analyzed and compared with the corresponding rates calculated from a healthy subject’s model to detect possible abnormalities. These rates are calculated from estimated values of glucose and insulin concentrations inside the corresponding organs/tissues from the physiological model. Estimation of the concentrations in body organs/tissues is carried out using a sequential Monte Carlo filtering method called particle filters. The results show that the proposed strategy is capable of detecting deficiencies in hepatic and peripheral glucose disposal, hepatic glucose production and pancreatic insulin secretion. The information provided by this strategy can potentially be used to tailor patient dietary requirements and/or select appropriate medications for the patients. Keywords Organ dysfunction diagnosis In silico clinical trial Particle filters Type II diabetes compartmental modeling